找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanomedicines for Brain Drug Delivery; Javier O. Morales,Pieter J. Gaillard Book 2021 Springer Science+Business Media, LLC, part of Spring

[復(fù)制鏈接]
樓主: endocarditis
31#
發(fā)表于 2025-3-26 21:15:22 | 只看該作者
Self-Assembling Peptide Nanofibrous Scaffolds in Central Nervous System Lesions,tential inhibitory molecules and glial scars, which inhibit axonal regeneration. Self-assembling peptide nanofibrous scaffolds (SAPNSs) which have been shown to mimic the structure of natural extracellular matrix (ECM) demonstrate the effectiveness in minimizing secondary injury as well as promoting
32#
發(fā)表于 2025-3-27 01:54:11 | 只看該作者
33#
發(fā)表于 2025-3-27 08:01:56 | 只看該作者
34#
發(fā)表于 2025-3-27 10:31:57 | 只看該作者
Magnetic Nanoparticles as Delivery Systems to Penetrate the Blood-Brain Barrier,d biodegradability, superparamagnetic iron oxide nanoparticles (SPIONs) show promise as carriers of therapeutics or as a therapeutic system in themselves. The use of SPIONs as a therapeutic system with the capacity to penetrate the BBB is based on three different strategies: (a) SPIONs are encapsula
35#
發(fā)表于 2025-3-27 13:39:15 | 只看該作者
Nose-to-Brain Drug Delivery Enabled by Nanocarriers,e treatment of central nervous system diseases is the blood-brain barrier. Over the last several decades, the intranasal route of delivery has been reported to provide a bypass of the blood-brain barrier, delivering drugs directly from the nose to the brain. In addition to the opportunities this rou
36#
發(fā)表于 2025-3-27 17:47:07 | 只看該作者
37#
發(fā)表于 2025-3-27 23:59:55 | 只看該作者
Safety and Nanotoxicity Aspects of Nanomedicines for Brain-Targeted Drug Delivery,ogies currently deficient of curative treatments, such as neurodegenerative disorders and malignant glioblastoma. Nevertheless, the neurotoxic effects exerted by several types of nanomaterials are the same as those involved in the pathology of neurodegeneration; thus it is important to have a deep k
38#
發(fā)表于 2025-3-28 05:56:58 | 只看該作者
Eduardo Gallardo-Toledo,Carolina Velasco-Aguirre,Marcelo Javier Kogan) bei Erwachsenen wurde unter Beratung und Moderation durch die Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) von einem Gremium erstellt, das 20 Fachverb?nde und andere Organisationen aus den Bereichen Psychotherapie, Psychologie, psychosomatische Medizin, Psychi
39#
發(fā)表于 2025-3-28 09:12:42 | 只看該作者
Joan Estelrich,Maria Antònia Busquets.Includes supplementary material: .Die deutsche S3-Leitline zur Behandlung von Angstst?rungen (Panikst?rung/Agoraphobie, generalisierte Angstst?rung, soziale Phobie, spezifische Phobie) bei Erwachsenen wurde unter Beratung und Moderation durch die Arbeitsgemeinschaft der Wissenschaftlichen Medizinis
40#
發(fā)表于 2025-3-28 12:20:31 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 23:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
十堰市| 梁山县| 高要市| 青田县| 蓝山县| 宾川县| 蒙山县| 仙桃市| 富蕴县| 青神县| 乐安县| 拉萨市| 昌黎县| 庆城县| 文登市| 吴川市| 喜德县| 富川| 济阳县| 融水| 兴海县| 新巴尔虎左旗| 福鼎市| 万盛区| 乡宁县| 吉木乃县| 潜山县| 大姚县| 红河县| 郓城县| 南木林县| 乐亭县| 苍梧县| 西丰县| 全南县| 大宁县| 馆陶县| 中方县| 仁化县| 大庆市| 湖州市|